Intranasal Dexamethasone Selectively Impairs Exploratory and Learning Behaviour While Sparing Peripheral Metabolic and Oxidative Homeostasis in Adult Mice
DOI:
https://doi.org/10.54548/Samenvatting
Dexamethasone (Dex) is a potent synthetic glucocorticoid with broad clinical applications, but systemic administration often leads to metabolic disturbances and cognitive side effects. Intranasal Dex has potential to deliver glucocorticoids directly to the brain, minimizing systemic side effects associated with traditional administration. However, its comprehensive effects on metabolic, behavioural, and neurochemical endpoints after repeated dosing remain unclear. Adult male mice were randomly assigned to four groups: control (saline) and dexamethasone (Dex) doses of 5, 15, or 50 μg/kg administered intranasally once daily for seven days. Peripheral measures included body weight, fasting blood glucose, glucose tolerance test (GTT), fasting serum and brain insulin levels, HOMA‑IR, and serum corticosterone via ELISA. Behavioural assays comprised the Morris Water Maze, Elevated Plus Maze, Open Field Test, and Novel Object Recognition Test. Brain homogenates were analysed for oxidative stress markers (superoxide dismutase, glutathione), cholinergic activity (acetylcholinesterase), and trace minerals (Zn, Fe, Ca). Intranasal Dex did not affect body weight, glycaemic control, insulin sensitivity, or corticosterone levels. Dose‑dependent declines in locomotor exploration and spontaneous alternation were observed, alongside increased escape latencies during spatial learning without altering memory retention or novel object recognition. Oxidative stress markers and global Zn, Fe, and Ca remained stable; however, acetylcholinesterase activity trended downward and variability in Fe and Ca emerged at higher doses. Seven-day intranasal Dex selectively impairs exploratory behaviour and learning acquisition through central glucocorticoid receptor–mediated synaptic and cholinergic modulation, while preserving peripheral metabolic and oxidative balance.
Referenties
Abdulbasit, A., Stephen Michael, F., Shukurat Onaopemipo, A., Abdulmusawwir, A. O., Aminu, I., Nnaemeka Tobechukwu, A., Wahab Imam, A., Oluwaseun Aremu, A., Folajimi, O., Bilikis Aderonke, A., Ridwan Babatunde, I., and Victor Bamidele, O. (2018). Glucocorticoid receptor activation selectively influence performance of Wistar rats in Y-maze. Pathophysiology, 25(1), 41–50. https://doi.org/10.1016/J.PATHOPHYS.2017.12.002
Batista, E. K., Lima, L. M. A. de, Gomes, D. A., Crans, D. C., Silva, W. E., Belian, M. F., and Lira, E. C. (2024). Dexamethasone-Induced Insulin Resistance Attenuation by Oral Sulfur–Oxidovanadium(IV) Complex Treatment in Mice. Pharmaceuticals, 17(6), 760. https://doi.org/10.3390/PH17060760/S1
Blin, J., Gautier, C., Aubert, P., Durand, T., Oullier, T., Aymeric, L., Naveilhan, P., Masson, D., Neunlist, M., and Bach-Ngohou, K. (2023). Psychological stress induces an increase in cholinergic enteric neuromuscular pathways mediated by glucocorticoid receptors. Frontiers in Neuroscience, 17, 1100473. https://doi.org/10.3389/FNINS.2023.1100473/BIBTEX
Cárdenas, G., Chávez-Canales, M., Espinosa, A. M., Jordán-Ríos, A., Malagon, D. A., Murillo, M. F. M., Araujo, L. V. T., Campos, R. L. B., Wong-Chew, R. M., González, L. E. R., Cresencio, K. I., Velázquez, E. G., de la Cerda, M. R., Leyva, Y., Hernández-Ruiz, J., Hernández-Medel, M. L., León-Hernández, M., Quero, K. M., Monciváis, A. S., … Sciutto, E. (2022). Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients. Trials, 23(1), 1–11. https://doi.org/10.1186/S13063-022-06075-5/FIGURES/1
Chen, H. J. C., Yip, T., Lee, J. K., Juliani, J., Sernia, C., Hill, A. F., Lavidis, N. A., and Spiers, J. G. (2020). Restraint Stress Alters Expression of Glucocorticoid Bioavailability Mediators, Suppresses Nrf2, and Promotes Oxidative Stress in Liver Tissue. Antioxidants 2020, Vol. 9, Page 853, 9(9), 853. https://doi.org/10.3390/ANTIOX9090853
Chen, H., Lombès, M., and Le Menuet, D. (2017). Glucocorticoid receptor represses brain-derived neurotrophic factor expression in neuron-like cells. Molecular Brain, 10(1). https://doi.org/10.1186/S13041-017-0295-X,
Cho, J. H., and Suh, S. (2024). Glucocorticoid-Induced Hyperglycemia: A Neglected Problem. Endocrinology and Metabolism, 39(2), 222–238. https://doi.org/10.3803/ENM.2024.1951
Coburn-Litvak, P. S., Pothakos, K., Tata, D. A., McCloskey, D. P., and Anderson, B. J. (2003). Chronic administration of corticosterone impairs spatial reference memory before spatial working memory in rats. Neurobiology of Learning and Memory, 80(1), 11–23. https://doi.org/10.1016/S1074-7427(03)00019-4
Coluccia, D., Wolf, O. T., Kollias, S., Roozendaal, B., Forster, A., and De Quervain, D. J. F. (2008). Glucocorticoid Therapy-Induced Memory Deficits: Acute versus Chronic Effects. The Journal of Neuroscience, 28(13), 3474. https://doi.org/10.1523/JNEUROSCI.4893-07.2008
Conrad, C. D., Peay, D. N., Acuña, A. M., Whittaker, K., and Donnay, M. E. (2024). Corticosterone disrupts spatial working memory during retention testing when highly taxed, which positively correlates with depressive-like behavior in middle-aged, ovariectomized female rats. Hormones and Behavior, 164. https://doi.org/10.1016/J.YHBEH.2024.105600
Ferreira, A., Neves, P., and Gozzelino, R. (2019). Multilevel Impacts of Iron in the Brain: The Cross Talk between Neurophysiological Mechanisms, Cognition, and Social Behavior. Pharmaceuticals 2019, Vol. 12, Page 126, 12(3), 126. https://doi.org/10.3390/PH12030126
Fowler, J., Rotenberg, B. W., and Sowerby, L. J. (2021). The subtle nuances of intranasal corticosteroids. Journal of Otolaryngology - Head and Neck Surgery, 50(1), 1–6. https://doi.org/10.1186/S40463-020-00480-Z/FIGURES/1
Hughes, K., Glass, C., Ripchinski, M., Gurevich, F., Weaver, T. E., Lehman, E., Fisher, L. H., and Craig, T. J. (2003). Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology, 58(5), 380–385. https://doi.org/10.1034/j.1398-9995.2003.00093.x
Jeanneteau, F., and Coutellier, L. (2022). The glucocorticoid footprint on the memory engram. Current Opinion in Endocrine and Metabolic Research, 25. https://doi.org/10.1016/j.coemr.2022.100378
Kim, M. H., Lee, G. S., Jung, E. M., Choi, K. C., and Jeung, E. B. (2009). The negative effect of dexamethasone on calcium-processing gene expressions is associated with a glucocorticoid-induced calcium-absorbing disorder. Life Sciences, 85(3–4), 146–152. https://doi.org/10.1016/J.LFS.2009.05.013
Koorneef, L. L., van der Meulen, M., Kooijman, S., Sánchez-López, E., Scheerstra, J. F., Voorhoeve, M. C., Ramesh, A. N. N., Rensen, P. C. N., Giera, M., Kroon, J., and Meijer, O. C. (2022). Dexamethasone-associated metabolic effects in male mice are partially caused by depletion of endogenous corticosterone. Frontiers in Endocrinology, 13, 960279. https://doi.org/10.3389/FENDO.2022.960279/BIBTEX
Krall, R., Gale, J. R., Ross, M. M., Tzounopoulos, T., and Aizenman, E. (2022). Intracellular zinc signaling influences NMDA receptor function by enhancing the interaction of ZnT1 with GluN2A. Neuroscience Letters, 790, 136896. https://doi.org/10.1016/j.neulet.2022.136896
Kreider, M. L., Aldridge, J. E., Cousins, M. M., Oliver, C. A., Seidler, F. J., and Slotkin, T. A. (2005). Disruption of rat forebrain development by glucocorticoids: Critical perinatal periods for effects on neural cell acquisition and on cell signaling cascades mediating noradrenergic and cholinergic neurotransmitter/neurotrophic responses. Neuropsychopharmacology, 30(10), 1841–1855. https://doi.org/10.1038/SJ.NPP.1300743;KWRD=MEDICINE
Li, H., Jiang, S., Yang, C., Yang, S., He, B., Ma, W., and Zhao, R. (2017). Long-Term Dexamethasone Exposure Down-Regulates Hepatic TFR1 and Reduces Liver Iron Concentration in Rats. Nutrients 2017, Vol. 9, Page 617, 9(6), 617. https://doi.org/10.3390/NU9060617
Li, J. X., and Cummins, C. L. (2022). Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions. Nature Reviews. Endocrinology, 18(9), 540. https://doi.org/10.1038/S41574-022-00683-6
Maurer, S. V., and Williams, C. L. (2017). The cholinergic system modulates memory and hippocampal plasticity via its interactions with non-neuronal cells. Frontiers in Immunology, 8(NOV), 299560. https://doi.org/10.3389/FIMMU.2017.01489/XML/NLM
Meneses, G., Gevorkian, G., Florentino, A., Bautista, M. A., Espinosa, A., Acero, G., Díaz, G., Fleury, A., Pérez Osorio, I. N., del Rey, A., Fragoso, G., Sciutto, E., and Besedovsky, H. (2017). Intranasal delivery of dexamethasone efficiently controls LPS‐induced murine neuroinflammation. Clinical and Experimental Immunology, 190(3), 304. https://doi.org/10.1111/CEI.13018
Numakawa, T., and Kajihara, R. (2024). An Interaction between Brain-Derived Neurotrophic Factor and Stress-Related Glucocorticoids in the Pathophysiology of Alzheimer’s Disease. International Journal of Molecular Sciences 2024, Vol. 25, Page 1596, 25(3), 1596. https://doi.org/10.3390/IJMS25031596
Pacheco, A., Aguayo, F. I., Aliaga, E., Muñoz, M., García-Rojo, G., Olave, F. A., Parra-Fiedler, N. A., García-Pérez, A., Tejos-Bravo, M., Rojas, P. S., Parra, C. S., and Fiedler, J. L. (2017). Chronic stress triggers expression of immediate early genes and differentially affects the expression of AMPA and NMDA subunits in dorsal and ventral hippocampus of rats. Frontiers in Molecular Neuroscience, 10, 274093. https://doi.org/10.3389/FNMOL.2017.00244/BIBTEX
Paul, S., Jeon, W. K., Bizon, J. L., and Han, J. S. (2015). Interaction of basal forebrain cholinergic neurons with the glucocorticoid system in stress regulation and cognitive impairment. Frontiers in Aging Neuroscience, 7(MAR). https://doi.org/10.3389/FNAGI.2015.00043
Popoli, M., Yan, Z., McEwen, B. S., and Sanacora, G. (2012). The stressed synapse: The impact of stress and glucocorticoids on glutamate transmission. Nature Reviews Neuroscience, 13(1), 22–37. https://doi.org/10.1038/NRN3138
Reichardt, S. D., Amouret, A., Muzzi, C., Vettorazzi, S., Tuckermann, J. P., Lühder, F., and Reichardt, H. M. (2021). The Role of Glucocorticoids in Inflammatory Diseases. Cells 2021, Vol. 10, Page 2921, 10(11), 2921. https://doi.org/10.3390/CELLS10112921
Roozendaal, B., Hahn, E. L., Nathan, S. V., De Quervain, D. J. F., and McGaugh, J. L. (2004). Glucocorticoid Effects on Memory Retrieval Require Concurrent Noradrenergic Activity in the Hippocampus and Basolateral Amygdala. Journal of Neuroscience, 24(37), 8161–8169. https://doi.org/10.1523/JNEUROSCI.2574-04.2004
Schäfer, S. C., Wallerath, T., Closs, E. I., Schmidt, C., Schwarz, P. M., Förstermann, U., and Lehr, H. A. (2005). Dexamethasone suppresses eNOS and CAT-1 and induces oxidative stress in mouse resistance arterioles. American Journal of Physiology - Heart and Circulatory Physiology, 288(1 57-1), 436–444. https://doi.org/10.1152/AJPHEART.00587.2004,
See, K. C. (2023). Impact of inhaled and intranasal corticosteroids on glucose metabolism and diabetes mellitus: A mini review. Http://Www.Wjgnet.Com/, 14(8), 1202–1211. https://doi.org/10.4239/WJD.V14.I8.1202
Strelow, D. N., Magalhães, L. S., Paim, M. P., Krüger, L. D., Neto, J. S. S., Brüning, C. A., and Bortolatto, C. F. (2023). Depressive-like behavior and cognitive impairment induced by acute administration of dexamethasone: Pharmacological effects of 2-phenyl-3-(phenylselanyl)benzofuran in female Swiss mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 125, 110772. https://doi.org/10.1016/J.PNPBP.2023.110772
Tappy, L., Randin, D., Vollenweider, P., Vollenweider, L., Paquot, N., Scherrer, U., Schneiter, P., Nicod, P., and Jéquier, E. (1994). Mechanisms of dexamethasone-induced insulin resistance in healthy humans. The Journal of Clinical Endocrinology and Metabolism, 79(4), 1063–1069. https://doi.org/10.1210/JCEM.79.4.7962275
Vazquez, S., Gold, J., Spirollari, E., Akmal, S., and Hanft, S. J. (2023). The story of dexamethasone and how it became one of the most widely used drugs in neurosurgery. Journal of Neurosurgery, 140(4), 1191–1197. https://doi.org/10.3171/2023.9.JNS231099
Wang, J., Zhao, J., Zhao, K., Wu, S., Chen, X., and Hu, W. (2024). The Role of Calcium and Iron Homeostasis in Parkinson’s Disease. Brain Sciences, 14(1), 88. https://doi.org/10.3390/BRAINSCI14010088
Wang, L., Yin, Y. L., Liu, X. Z., Shen, P., Zheng, Y. G., Lan, X. R., Lu, C. B., and Wang, J. Z. (2020). Current understanding of metal ions in the pathogenesis of Alzheimer’s disease. Translational Neurodegeneration 2020 9:1, 9(1), 1–13. https://doi.org/10.1186/S40035-020-00189-Z
Wang, Y., Zhang, Y., Hu, J., Pan, C., Gao, Y., Liu, Q., Xu, W., Xue, L., and Hu, C. (2023). Glucocorticoids modulate neural activity via a rapid non-genomic effect on Kv2.2 channels in the central nervous system. Neurobiology of Stress, 28, 100593. https://doi.org/10.1016/J.YNSTR.2023.100593
Gepubliceerd
Nummer
Sectie
Licentie
Auteursrecht (c) 2025 Nigerian Journal of Physiological Sciences
Dit artikel is gelicentieerd onder de Naamsvermelding 4.0 Internationaal licentie.
